Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CCR5”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Testing effectiveness (Phase 2)Ended earlyNCT02355184
What this trial is testing

An Extension of Protocol PRO 140_CD01 Study

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 20
Early research (Phase 1)Study completedNCT01140425
What this trial is testing

Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

Who this might be right for
Healthy
Pfizer 44
Not applicableUnknownNCT00988780
What this trial is testing

Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients

Who this might be right for
Immune Reconstitution Inflammatory SyndromeHIVHIV Infections
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 276
Large-scale testing (Phase 3)Study completedNCT00098306
What this trial is testing

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Who this might be right for
HIV Infections
ViiV Healthcare 601
Testing effectiveness (Phase 2)Looking for participantsNCT06699836
What this trial is testing

Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
CytoDyn, Inc. 60
Not applicableStudy completedNCT00709111
What this trial is testing

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 34
Early research (Phase 1)WithdrawnNCT03118661
What this trial is testing

Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant

Who this might be right for
HIV-1-infection
Washington University School of Medicine
Post-approval studies (Phase 4)Ended earlyNCT01068873
What this trial is testing

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Who this might be right for
HIV Infections
Temple University 1
Testing effectiveness (Phase 2)WithdrawnNCT05730673
What this trial is testing

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

Who this might be right for
CCR5Microsatellite StableMetastatic+1 more
CytoDyn, Inc.
Large-scale testing (Phase 3)Study completedNCT00098748
What this trial is testing

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
ViiV Healthcare 190
Testing effectiveness (Phase 2)Study completedNCT00795444
What this trial is testing

Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1

Who this might be right for
HIV-1
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Early research (Phase 1)Study completedNCT01290211
What this trial is testing

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Who this might be right for
Healthy
ViiV Healthcare 28
Testing effectiveness (Phase 2)Study completedNCT02330549
What this trial is testing

ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD

Who this might be right for
Prediabetic StateNon-alcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
Tobira Therapeutics, Inc. 45
Very early researchEnded earlyNCT02486510
What this trial is testing

Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication

Who this might be right for
HIV-1 Infection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 7
Testing effectiveness (Phase 2)Looking for participantsNCT06853223
What this trial is testing

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Who this might be right for
Primary Graft DysfunctionLung TransplantationAcute Lung Injury(ALI)+1 more
University of California, San Francisco 120
Testing effectiveness (Phase 2)Study completedNCT00766597
What this trial is testing

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 9
Large-scale testing (Phase 3)Study completedNCT01348308
What this trial is testing

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

Who this might be right for
HIV-1 InfectionAIDS
ANRS, Emerging Infectious Diseases 407
Not applicableStudy completedNCT01076179
What this trial is testing

Kaletra in Combination With Antiretroviral Agents

Who this might be right for
Human Immunodeficiency Virus
AbbVie (prior sponsor, Abbott) 502
Early research (Phase 1)Study completedNCT00703586
What this trial is testing

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

Who this might be right for
HIV Infections
Rockefeller University 8
Testing effectiveness (Phase 2)Study completedNCT04504942
What this trial is testing

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Adult
CytoDyn, Inc. 16
Load More Results